You are here: Urology Textbook > Index > Bioavailability and first-pass effect
Bioavailability and First-Pass Effect of Drugs
Definition of Bioavailability
Bioavailability describes the (unchanged) fraction of a drug, which appears within the blood circulation after administration. By definition, intravenous administration correlates with 100% bioavailability. Various mechanisms such as incomplete absorption and first-pass effect reduce the bioavailability of orally administered drugs.
Mechanisms of a Low Bioavailability of Oral Medication
Only dissolved drugs can be absorbed by the gastrointestinal tract.
The absorption of drugs through the intestinal wall is time dependent and is affected by the velocity of gastrointestinal passage. Diseases such as diarrhea, vomiting, short bowel syndrome or gastrointestinal fistulas are additional mechanisms of incomplete absorption.
First-Pass Effect in the Intestine and Liver
After gastrointestinal absorption, drugs may be metabolized and inactivated in the intestinal wall (e.g., catecholamines). Subsequently, the drug enters the portal circulation to the liver. Depending on the liver function and enzyme activity, further inactivation of the drug may occur (e.g., morphine). The first pass effect can be minimized by rectal, sublingual, transdermal, subcutaneous, intramuscular or nasal administration.
Index: 1–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Deutsche Version: Bioverfügbarkeit